Invitrogen's Onions Heads to BioReliance; Millipore to Replace CFO; Gene Logic Promotes Brinkerhoff; BIO Fleshes Out Board; and Others | GenomeWeb

NEW YORK (GenomeWeb News) — BioReliance has appointed David Onions CSO, effective June 18. Onions will run the company’s global clinical and preclinical scientific activities, the company said. Onions comes to BioReliance from Invitrogen, where he was CMO.

Millipore said Kathleen Allen is leaving her post as CFO, and has selected Charles Wagner to take her position.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.